Skip to content

Evaluation of AG-181 in Subjects 18 to 69 Years of Age With Phenylketonuria

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-522630-31-00
Enrollment
10
Registered
2026-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phenylketonuria

Interventions

None listed

Sponsors

Agios Pharmaceuticals Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Apr 4, 2026